Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- AMA urges physician protections against AI deepfake impersonation
- 4/30/2026 10:11:23 AM
- Responding to the escalating risk of AI-manipulated images, videos and audio that impersonate physicians, the American Medical Association (AMA) today announced a new comprehensive policy framework to establish clear, enforceable protections for physicians against unauthorized AI-generated “deepfakes.” Created by the AMA Center for Digital Health and AI, the framework …
- Study: Immigrants help address the US eldercare shortage
- 4/30/2026 10:06:21 AM
- Good caregivers are often in short supply, but after the Covid-19 pandemic hit the U.S. in early 2020, staff levels at nursing homes dropped by 10 percent.
- Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
- 4/29/2026 1:33:28 PM
- Sanofi’s Mixed General Meeting of Shareholders convened on April 29, 2026, under the chairmanship of Frédéric Oudéa. All resolutions were approved with a high level of shareholder support, in particular the appointment of Belén Garijo as a board member.
- Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
- 4/28/2026 11:48:30 AM
- Johnson & Johnson (NYSE: JNJ) will present at the Bernstein’s 42 nd Annual Strategic Decisions Conference on Wednesday, May 27 th, 2026. Management will participate in a Fireside Chat at 11:00 a.m.
- Novel Study Maps Changes in US Immigration Policy Landscape Since 9/11
- 4/28/2026 11:26:15 AM
- In a comprehensive analysis of state and local sanctuary and anti-sanctuary policies, researchers have mapped the rapidly evolving legal immigration landscape in the US from 2000 to 2021.
- “Bride and Blades” Shows How Marriage and Medicine Can Thrive Together
- 4/27/2026 9:11:38 PM
- Dr. Albert H. Yurvati, DO, PhD, DSc(hc), FACOS, FAHA, introduces his compelling new release, “Bride and Blades: How to Survive a Surgical Marriage.” Part memoir, part manual, the book explores how couples can endure the rigorous demands of medical careers while sustaining love and commitment.
- Sanofi successfully prices 2.3 billion of bond issue
- 4/27/2026 6:35:18 PM
- Sanofi announces that it has successfully priced its offering of €2.3 billion of notes across 3 tranches: • €1,000 million fixed-rate notes, due May 2029, bearing interest at an annual rate of 3.000% • €650 million fixed-rate notes, due May 2033, bearing interest at an annual rate of 3.375% • €650 million fixed-rate notes, due May 2037, bearing interest at an …
- Blockchain in Healthcare Today Reaches H-Index 12 Expanding PubMed Indexed Digital Health Research Impact
- 4/27/2026 8:00:00 AM
- Blockchain in Healthcare Today (BHTY), a peer-reviewed open access journal focused on blockchain and decentralized technologies in healthcare and life sciences, has reached an H-index of 12, according to SCImago SJR 2025 data.
- Dr. Albert H. Yurvati Offers an Honest Insight into Life in a Surgical Marriage
- 4/23/2026 9:57:21 PM
- Author Dr. Albert H. Yurvati, DO, PhD, DSc(hc), FAHA, DFACOS, brings readers a unique blend of memoir and practical advice in “Bride and Blades: How to Survive a Surgical Marriage.” His story spans decades of surgical practice alongside a marriage of over 50 years, offering wisdom to couples navigating the pressures of medicine.
- Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
- 4/23/2026 11:08:24 AM
- • Approval for children aged two to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical study program • CSU is a chronic skin disease that causes itch and hives that can be debilitating for young children, especially for those whose disease remains uncontrolled • CSU marks the fifth disease …
- How do patients’ relatives and friends view the benefits and harms of electroconvulsive therapy?
- 4/23/2026 10:07:34 AM
- Electroconvulsive therapy (ECT), which involves passing electricity through the brain under general anesthesia to cause a seizure, usually between six and twelve times, is used to varying degrees around the world for patients with depression and other mental conditions.
- AMA urges Congress to strengthen safeguards for AI chatbots
- 4/22/2026 12:15:34 PM
- The American Medical Association (AMA) today urged federal lawmakers to put stronger safeguards in place as the use of augmented intelligence (AI) chatbots in mental health care continues to grow.
- Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
- 4/22/2026 11:18:17 AM
- • Expanded approval includes children aged one year and above with stage 2 T1D to delay the onset of stage 3 • Tzield is the first disease-modifying therapy for children aged one year and above diagnosed with stage 2 T1D The US Food and Drug Administration (FDA) has approved the supplemental biologic license application for Tzield (teplizumab-mzwv), expanding the …
- AMA: Physician burnout rates are falling, specialty gaps remain
- 4/20/2026 11:06:30 AM
- New data from the American Medical Association (AMA) show physician burnout continuing to decline nationwide, but significant differences across medical specialties underscore the need for more targeted solutions within health systems.
- Telehealth and Medicine Today Achieves Q2 SCImago Ranking Advancing Its Global Research Presence
- 4/20/2026 8:00:00 AM
- Telehealth and Medicine Today (THMT), the peer-reviewed open access journal published by Partners in Digital Health, has achieved a Q2 quartile ranking in SCImago Journal Rank 2025—placing it in the top half of journals globally and reflecting the journal’s growing interdisciplinary reach and the quality of research it has published since its founding.
- Novel Research Reveals the Active Role that Skin Cells Play in Rabies Infection
- 4/17/2026 12:21:02 PM
- While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to pass through, novel research reveals that these cells play a much more active role.
- Osteoboost Secures $8M to Expand Access to its FDA-Cleared Prescription Wearable for Bone Health
- 4/15/2026 12:00:00 PM
- Osteoboost Health, Inc., today announced it has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden the commercial reach of the company’s FDA-cleared medical device for low bone density.
- UK start-ups to power a new wave of quantum innovation
- 4/15/2026 11:02:24 AM
- The start-ups have joined the DeepTech Catalyst Quantum incubator programme (DTC Quantum), where they will use quantum technologies to develop and commercialise new products designed to deliver practical, real-world benefits.
- FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development
- 4/15/2026 10:11:56 AM
- The U.S. Food and Drug Administration issued a draft guidance for sponsors seeking approval of human gene therapy products involving genome editing technologies.
- AMA launches “Health vs. Hype” podcast series with iHeartMedia
- 4/15/2026 10:05:05 AM
- The American Medical Association (AMA), in collaboration with iHeartMedia’s Ruby studio, today announced the launch of its new podcast series, “Health vs.